Insider Selling: Penumbra Inc (NYSE:PEN) EVP Sells 6,000 Shares of Stock

Penumbra Inc (NYSE:PEN) EVP Lynn Rothman sold 6,000 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $90.99, for a total transaction of $545,940.00. Following the completion of the sale, the executive vice president now owns 159,519 shares in the company, valued at approximately $14,514,633.81. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Penumbra Inc (NYSE:PEN) traded up $1.00 during mid-day trading on Friday, reaching $90.30. 296,479 shares of the company traded hands, compared to its average volume of 231,853. The firm has a market capitalization of $3,064.69, a price-to-earnings ratio of -410.45, a PEG ratio of 96.75 and a beta of 0.19. Penumbra Inc has a 52 week low of $70.40 and a 52 week high of $116.35.

A number of research firms have recently weighed in on PEN. Canaccord Genuity increased their price objective on shares of Penumbra from $100.00 to $113.00 and gave the stock a “buy” rating in a research note on Wednesday, November 8th. Zacks Investment Research lowered shares of Penumbra from a “hold” rating to a “sell” rating in a research note on Wednesday, January 10th. BMO Capital Markets lowered shares of Penumbra from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $117.00 to $110.00 in a research note on Tuesday, December 12th. They noted that the move was a valuation call. Finally, JPMorgan Chase & Co. lowered shares of Penumbra from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 2nd. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $111.50.

A number of hedge funds have recently added to or reduced their stakes in PEN. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Penumbra by 10.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,159 shares of the company’s stock valued at $102,000 after buying an additional 114 shares during the period. Simplex Trading LLC lifted its holdings in Penumbra by 116.2% during the fourth quarter. Simplex Trading LLC now owns 1,911 shares of the company’s stock valued at $179,000 after purchasing an additional 1,027 shares in the last quarter. Public Employees Retirement Association of Colorado purchased a new position in Penumbra during the fourth quarter valued at $189,000. Verition Fund Management LLC purchased a new position in Penumbra during the second quarter valued at $213,000. Finally, Teacher Retirement System of Texas purchased a new position in Penumbra during the third quarter valued at $214,000. Institutional investors own 71.57% of the company’s stock.

WARNING: This story was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at

About Penumbra

Penumbra, Inc is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Insider Buying and Selling by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with's FREE daily email newsletter.

Leave a Reply